Literature DB >> 28741619

Pancreatic Cancer: EGFR inhibition is effective against KRAS-wild-type disease.

Peter Sidaway.   

Abstract

Entities:  

Year:  2017        PMID： 28741619     DOI： 10.1038/nrclinonc.2017.119

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  5 in total

Review 1.  Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.

Authors:  Fawz S AlHarthi; Alya Qari; Alaa Edress; Malak Abedalthagafi
Journal:  NPJ Genom Med       Date:  2020-02-03       Impact factor: 8.617

2.  Anti-Tumor Effects of MAPK-Dependent Tumor-Selective Oncolytic Vaccinia Virus Armed with CD/UPRT against Pancreatic Ductal Adenocarcinoma in Mice.

Authors:  Hajime Kurosaki; Motomu Nakatake; Teruhisa Sakamoto; Nozomi Kuwano; Masato Yamane; Kenta Ishii; Yoshiyuki Fujiwara; Takafumi Nakamura
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

3.  The miR-141/neuropilin-1 axis is associated with the clinicopathology and contributes to the growth and metastasis of pancreatic cancer.

Authors:  Lixin Ma; Bo Zhai; Huaqiang Zhu; Weidong Li; Wenjing Jiang; Liwang Lei; Shujun Zhang; Haiquan Qiao; Xian Jiang; Xueying Sun
Journal:  Cancer Cell Int       Date:  2019-09-27       Impact factor: 5.722

4.  Berbamine Enhances the Efficacy of Gefitinib by Suppressing STAT3 Signaling in Pancreatic Cancer Cells.

Authors:  Bingren Hu; Huajie Cai; Shouzhang Yang; Jinfu Tu; Xiaming Huang; Gang Chen
Journal:  Onco Targets Ther       Date:  2019-12-24       Impact factor: 4.147

Review 5.  Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.

Authors:  Yunzhen Qian; Yitao Gong; Zhiyao Fan; Guopei Luo; Qiuyi Huang; Shengming Deng; He Cheng; Kaizhou Jin; Quanxing Ni; Xianjun Yu; Chen Liu
Journal:  J Hematol Oncol       Date:  2020-10-02       Impact factor: 17.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.